Table 2 Relationship of race, BMI, and lung cancer development
From: Racial difference in BMI and lung cancer diagnosis: analysis of the National Lung Screening Trial
Underweight/ normal | Overweight | Obese | p-value | ||||
|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Race | .001 | ||||||
Non-Hispanic Whites (NHW) | 13,725 | 28.8% | 20,484 | 43.1% | 13,385 | 28.1% | |
African-Americans | 621 | 26.7% | 917 | 39.3% | 787 | 33.9% | |
Others | 896 | 30.6% | 1,264 | 43.1% | 771 | 26.3% | |
Lung cancer diagnosis (n = 2037) | |||||||
Total | 747 | 4.9% | 867 | 3.8% | 423 | 2.8% | .001 |
NHW | 678 | 4.9% | 794 | 3.8% | 387 | 2.8% | .001 |
African-Americans | 32 | 5.1% | 46 | 4.9% | 24 | 3.0% | .083 |
Others | 21 | 4.9% | 13 | 2.7% | 2 | 1.2% | .041a |
Lung cancer Stage | .144 | ||||||
Stage I & II | 343 | 46.4% | 435 | 50.7% | 191 | 46.0% | |
Stage III & IV | 396 | 53.5% | 423 | 49.3% | 224 | 54.0% | |
Lung cancer histology type | .03 | ||||||
Adenocarcinoma | 331 | 45.0% | 393 | 45.8% | 166 | 39.7% | |
Squamous cell carcinoma | 152 | 20.7% | 217 | 25.3% | 89 | 21.3% | |
Small cell carcinoma | 106 | 14.4% | 107 | 12.5% | 72 | 17.2% | |
Carcinoid/Neuroendocrine tumor | 18 | 2.5% | 22 | 2.6% | 19 | 4.6% | |
Large cell carcinoma | 20 | 2.7% | 19 | 2.2% | 13 | 3.1% | |
Non-Small cell carcinoma or other | 109 | 14.8% | 101 | 11.8% | 59 | 14.1% | |